The site uses anonymous third party analytic cookies: in accessing any element/area of the site outside of this banner, you consent to receiving cookies.

What role for pharma in helping to deliver integrated care?

Steve How and Paul Midgley, of Wilmington Healthcare, explore how pharma can support local health economies in providing joined-up, holistic...

New NHS systems redefine procurement strategy

Steve How, of Wilmington Healthcare, explains why MedTech companies need to align their value proposition with the integrated care agenda The...

Looking ahead 2019 – The NHS Long-term Plan: What does it mean for industry?

To understand your NHS customer, you must understand the Plan Do you know how it will affect the NHS payer landscape and how healthcare services...

How will NHS services evolve in the next decade?

Oli Hudson and Steve How, of the Wilmington Healthcare Consulting Team, explore some of the key goals set out in the Long-term Plan NHS...

How can MedTech help the NHS transform procurement?

NHS Supply Chain category tower service provider director, Mark Hart, explains what he needs from the MedTech industry in a Wilmington Healthcare...

Putting disease prevention on a par with cure

Steve How and Paul Midgley, of the Wilmington Healthcare Consulting Team, explore how the NHS is taking an increasingly holistic approach to care...

What does the new NHS plan mean for pharma?

The NHS reaffirmed its commitment to integrated care systems in its highly-anticipated ‘Long-term Plan’, which provides a blueprint for the...

Join the conversation: Whatever happened to accountable care?

The controversy around use of the phrase ‘accountable care’ has forced a shift to a more positive focus on ‘integrated care’ Steve How,...

Medtech innovation is key for new NHS plan

The ‘Long-term Plan’, which was unveiled this month, provides critical insights into where and how money will be spent to accelerate the redesign...

Join the conversation: Procurement and the Future Operating Model

The Future Operating Model (FOM) is now THE operating model and was introduced following the Carter Review to encourage transparency and...

Join the conversation: What are Regional Medicines Optimisation Committees (RMOCs)?

What is the purpose of RMOCs, what benefits do they provide to the NHS and what is their impact on industry Steve How, Programme Director and...

NHS medicines optimisation milestone

Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European...

How will category towers tackle NHS procurement challenges?

Steve How and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore how the procurement towers plan to reduce unwarranted variation in...

How can pharma support NHS service transformation?

Wilmington Healthcare’s recent webinar explored how pharma can assist the NHS in delivering integrated care To help pharma companies keep...